Figure 7. Structural formulas of A) ACE and B) EGFR inhibitors with designed on their basis highly specific fragments. Circles indicate the regions of inhibitors’ structural motifs required for binding with their molecular targets [24-27] and the corresponding regions in the constructed fragments.